375 related articles for article (PubMed ID: 33949441)
1. Immunomodulatory nanomedicine for colorectal cancer treatment: a landscape to be explored?
Silveira MJ; Castro F; Oliveira MJ; Sarmento B
Biomater Sci; 2021 May; 9(9):3228-3243. PubMed ID: 33949441
[TBL] [Abstract][Full Text] [Related]
2. Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy.
Abdelgalil RM; Elmorshedy YM; Elkhodairy KA; Teleb M; Bekhit AA; Khattab SN; Elzoghby AO
Nanomedicine (Lond); 2022 Sep; 17(22):1721-1745. PubMed ID: 36621872
[TBL] [Abstract][Full Text] [Related]
3. Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy.
Mao Q; Min J; Zeng R; Liu H; Li H; Zhang C; Zheng A; Lin J; Liu X; Wu M
Theranostics; 2022; 12(14):6088-6105. PubMed ID: 36168633
[TBL] [Abstract][Full Text] [Related]
4. Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment.
Sun B; Hyun H; Li LT; Wang AZ
Acta Pharmacol Sin; 2020 Jul; 41(7):970-985. PubMed ID: 32424240
[TBL] [Abstract][Full Text] [Related]
5. Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.
Ren SN; Zhang ZY; Guo RJ; Wang DR; Chen FF; Chen XB; Fang XD
World J Gastroenterol; 2023 Apr; 29(13):1911-1941. PubMed ID: 37155531
[TBL] [Abstract][Full Text] [Related]
6. Remodeling tumor microenvironment with nanomedicines.
Martin JD; Miyazaki T; Cabral H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1730. PubMed ID: 34124849
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.
Zanganeh S; Spitler R; Hutter G; Ho JQ; Pauliah M; Mahmoudi M
Immunotherapy; 2017 Sep; 9(10):819-835. PubMed ID: 28877626
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine-Based Immunotherapy for the Treatment of Cancer Metastasis.
Zhang P; Zhai Y; Cai Y; Zhao Y; Li Y
Adv Mater; 2019 Dec; 31(49):e1904156. PubMed ID: 31566275
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy.
Zhu Y; Yu X; Thamphiwatana SD; Zheng Y; Pang Z
Acta Pharm Sin B; 2020 Nov; 10(11):2054-2074. PubMed ID: 33304779
[TBL] [Abstract][Full Text] [Related]
10. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy.
Huang Y; Fan H; Ti H
Asian J Pharm Sci; 2024 Apr; 19(2):100902. PubMed ID: 38595331
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
[TBL] [Abstract][Full Text] [Related]
13. The Janus Face of Tumor Microenvironment Targeted by Immunotherapy.
Buoncervello M; Gabriele L; Toschi E
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484464
[TBL] [Abstract][Full Text] [Related]
14. The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy.
Kamal Y; Schmit SL; Frost HR; Amos CI
Immunotherapy; 2020 Oct; 12(14):1083-1100. PubMed ID: 32787587
[TBL] [Abstract][Full Text] [Related]
15. Tumor vasculature normalization by orally fed erlotinib to modulate the tumor microenvironment for enhanced cancer nanomedicine and immunotherapy.
Chen Q; Xu L; Chen J; Yang Z; Liang C; Yang Y; Liu Z
Biomaterials; 2017 Dec; 148():69-80. PubMed ID: 28968536
[TBL] [Abstract][Full Text] [Related]
16. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges.
Martin JD; Cabral H; Stylianopoulos T; Jain RK
Nat Rev Clin Oncol; 2020 Apr; 17(4):251-266. PubMed ID: 32034288
[TBL] [Abstract][Full Text] [Related]
17. Nanotherapeutic approaches targeting angiogenesis and immune dysfunction in tumor microenvironment.
Hameed S; Bhattarai P; Dai Z
Sci China Life Sci; 2018 Apr; 61(4):380-391. PubMed ID: 29607461
[TBL] [Abstract][Full Text] [Related]
18. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.
Subtil B; Cambi A; Tauriello DVF; de Vries IJM
Front Immunol; 2021; 12():724883. PubMed ID: 34691029
[TBL] [Abstract][Full Text] [Related]
19. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.
Gao S; Yang D; Fang Y; Lin X; Jin X; Wang Q; Wang X; Ke L; Shi K
Theranostics; 2019; 9(1):126-151. PubMed ID: 30662558
[TBL] [Abstract][Full Text] [Related]
20. Immune Adaptation of Colorectal Cancer Stem Cells and Their Interaction With the Tumor Microenvironment.
Lin CC; Liao TT; Yang MH
Front Oncol; 2020; 10():588542. PubMed ID: 33312953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
